BackDBV Technologies Overview

DBV Technologies Net Income

DBV Technologies's net income is $-160M, below the Healthcare sector average of $17B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$41.90M
26.52% YoY

As of Jun 2026

Annual Net Income (TTM)

-$164.74M
64.83% YoY

Trailing 12 months ending Jun 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

DBV Technologies (DBVT) FAQ

DBV Technologies (DBVT) currently reports a net income of $-160M as of June 2026. That compares with $-100M in the prior-year period — down 64.8% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore DBV Technologies's net income history and peer comparisons.

DBV Technologies's net income decreased from $-100M to $-160M — a 64.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DBV Technologies's net income of $-160M is lower than the Healthcare sector average of $17B. That is roughly 101.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

DBV Technologies reported $-160M in net income as of June 2026. That compares with $-100M in the prior-year period — down 64.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-160M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for DBV Technologies, and consider following DBVT for alerts when major investors trade the stock.